We are live on
!
Find out more
DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$59.2B
1-Year Est. Return
26.02%
This Fund
S&P 500
This Quarter
Est. Return
+7.62%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$16.9B
AUM Growth
+$1.55B
(+10%)
Cap. Flow
+$560M
Cap. Flow
% of AUM
3.31%
Top 10 Holdings %
Top 10 Hldgs %
18.6%
Holding
1,263
New
50
Increased
577
Reduced
391
Closed
38
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$57.5M |
| 2 |
Emerson Electric
EMR
|
+$45M |
| 3 |
Johnson & Johnson
JNJ
|
+$41.1M |
| 4 |
WEC Energy
WEC
|
+$36.5M |
| 5 |
Clorox
CLX
|
+$31.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PX
Praxair Inc
PX
|
+$63.8M |
| 2 |
Chevron
CVX
|
+$33.9M |
| 3 |
SLB Ltd
SLB
|
+$32.7M |
| 4 |
Lam Research
LRCX
|
+$22.8M |
| 5 |
Merck
MRK
|
+$21.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.91% |
| 2 | Healthcare | 16.61% |
| 3 | Financials | 14.79% |
| 4 | Communication Services | 9.7% |
| 5 | Industrials | 8.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Genuine Parts
GPC
$18.5B
| $1.55M | 0.01% |
14,928
+673
| +5% | +$66K |
|
677
Core Laboratories
CLB
$561M
| $1.55M | 0.01% |
13,500
| – | – |
|
678
Arrowhead Research
ARWR
$12.5B
| $1.54M | 0.01% |
107,200
+22,200
| +26% | +$364K |
|
|
MDCO
679
DELISTED
Medicines Co
MDCO
| $1.53M | 0.01% |
37,800
-300
| -0.8% | -$11.3K |
|
680
Benchmark Electronics
BHE
$2.92B
| $1.51M | 0.01% |
58,691
| – | – |
|
681
Haemonetics
HAE
$3.94B
| $1.51M | 0.01% |
13,749
+2,165
| +19% | +$224K |
|
682
Western Union
WU
$2.19B
| $1.51M | 0.01% |
78,047
+2,108
| +3% | +$40.9K |
|
|
WRK
683
DELISTED
WestRock Company
WRK
| $1.51M | 0.01% |
26,090
-1,062
| -4% | -$59.5K |
|
684
Entergy
ETR
$49.3B
| $1.51M | 0.01% |
34,428
-2,120
| -6% | -$87.6K |
|
685
Host Hotels & Resorts
HST
$15.5B
| $1.51M | 0.01% |
66,007
+4,868
| +8% | +$103K |
|
686
Heron Therapeutics
HRTX
$63.4M
| $1.5M | 0.01% |
39,000
-1,000
| -3% | -$37.2K |
|
687
Acuity Brands
AYI
$10.6B
| $1.49M | 0.01% |
9,643
+2,146
| +29% | +$308K |
|
688
ICICI Bank
IBN
$108B
| $1.49M | 0.01% |
154,912
| – | – |
|
689
Steris
STE
$23.3B
| $1.48M | 0.01% |
12,929
+631
| +5% | +$71.4K |
|
690
Ingredion
INGR
$6.53B
| $1.48M | 0.01% |
14,013
-9,766
| -41% | -$997K |
|
|
SLCA
691
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $1.47M | 0.01% |
+70,000
| New | +$1.62M |
|
692
LivaNova
LIVN
$4.21B
| $1.46M | 0.01% |
11,600
| – | – |
|
693
Rollins
ROL
$17.9B
| $1.46M | 0.01% |
53,573
-1,237
| -2% | -$31.9K |
|
694
Mercado Libre
MELI
$92.5B
| $1.45M | 0.01% |
4,057
+291
| +8% | +$98.5K |
|
|
JOYY
695
JOYY Inc
JOYY
$3.77B
| $1.45M | 0.01% |
5,617
| – | – |
|
696
Brunswick
BC
$5.21B
| $1.45M | 0.01% |
21,822
+1,050
| +5% | +$69.5K |
|
697
Amdocs
DOX
$6.22B
| $1.44M | 0.01% |
21,990
| – | – |
|
698
Tractor Supply
TSCO
$18B
| $1.43M | 0.01% |
78,545
-130
| -0.2% | -$2.16K |
|
|
LSXMA
699
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $1.43M | 0.01% |
41,669
+553
| +1% | +$18.6K |
|
700
Sensient Technologies
SXT
$5.51B
| $1.42M | 0.01% |
20,100
-10,500
| -34% | -$749K |
|
Similar funds
QCM
NAMI
DekaBank Deutsche Girozentrale's Q3 2018 Portfolio in Review
As of Q3 2018, DekaBank Deutsche Girozentrale held 1,263 positions worth $16.9B, up 10% from $15.4B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
DekaBank Deutsche Girozentrale deployed $560M of net new capital in Q3 2018, opening 50 new positions and adding to 577 existing holdings. Its largest new stake was Tilray: 8,950 shares worth $5.29M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Praxair Inc, an estimated $63.8M trimmed.
- DekaBank Deutsche Girozentrale's largest Q3 2018 buy was Tilray: 8,950 shares worth $5.29M.
- DekaBank Deutsche Girozentrale added most to Pfizer in Q3 2018, an estimated $57.5M increase.
- DekaBank Deutsche Girozentrale's biggest Q3 2018 reduction was Praxair Inc, cutting an estimated $63.8M.
- DekaBank Deutsche Girozentrale fully exited J.C. Penney Company, Inc. in Q3 2018, selling an estimated $3.94M.
- DekaBank Deutsche Girozentrale's ten largest holdings make up 19% of its $16.9B portfolio in Q3 2018.
- DekaBank Deutsche Girozentrale opened 50 new positions and closed 38 in Q3 2018.
- DekaBank Deutsche Girozentrale's portfolio value rose 10% quarter-over-quarter to $16.9B.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q3 2018, filed 9 Nov 2018.